Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Sonrotoclax overcomes BCL2 G101V mutation–induced venetoclax resistance in preclinical models of hematologic malignancy

Blood (2024) 143 (18): 1825–1836.

https://doi.org/10.1182/blood.2023019706

Published: 2024

Includes: Supplemental data

Journal Articles

Monitoring the Sign & Symptoms of Variant Creutzfeldt-Jakob Disease Among Patients with Multiple Myeloma Treated with Ixazomib Capsules in China: A Real-World Pharmacovigilance Survey

Zhongjun Xia, Xiaolin Xia, Lin Li, Sha Liu

Blood (2023) 142 (Supplement 1): 6629.

https://doi.org/10.1182/blood-2023-179108

Published: 2023

Journal Articles

A Multi-Center Retrospective Analysis of Outcomes Post Allogeneic Stem Cell Transplantation in AML Patients with TET2 Mutations: A Study on Behalf of the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Blood (2023) 142 (Supplement 1): 4986.

https://doi.org/10.1182/blood-2023-185685

Published: 2023

Journal Articles

Comparative Study for Haplo, MSD and MUD Allo-Hcts for AML Patients with KMT2A Rearrangement: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Blood (2023) 142 (Supplement 1): 660.

https://doi.org/10.1182/blood-2023-185557

Published: 2023

Journal Articles

Comparative Study for Haplo, MSD and MUD Allo-Hcts for Core-Binding Factor AML Patients in CR2: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Blood (2023) 142 (Supplement 1): 659.

https://doi.org/10.1182/blood-2023-186735

Published: 2023

Journal Articles

Treatment Patterns and Outcomes in Patients with Multiple Myeloma Who Received Ixazomib and in Patients with Triple-Class Refractory Multiple Myeloma: A Retrospective, Observational, Real-World Historical Database Analysis Study from China

Gang An, Lin Li, Sha Liu, Lugui Qiu

Blood (2023) 142 (Supplement 1): 6710.

https://doi.org/10.1182/blood-2023-182729

Published: 2023

Journal Articles

Characteristics and Safety Profile in Patient Received Ixazomib in China: Interim Analysis of a National, Prospective, Non-Interventional Study of Using Ixazomib in Real-World Clinical Practice (INFINITE Study)

Chengcheng Fu, Xin Zhou, Junling Zhuang, Fan Zhou, Yuhua Li, Wenming Chen, Rong Fu, Baijun Fang, Ting Niu, Hao Zhang, Lin Li, Depei Wu

Blood (2022) 140 (Supplement 1): 12642–12644.

https://doi.org/10.1182/blood-2022-165127

Published: 2022

Journal Articles

Gut-Bile Acid-Immune Axis Regulates T Cell Homeostasis in the Pathogenesis of Immune Thrombocytopenia

Feng-Qi Liu, Qingyuan Qu, Yu-xiu Chen, Qi Chen, Meng-lin Li, Xueyan Sun, Hai-xia Fu, Kaiyan Liu, Xiao-hui Zhang

Blood (2022) 140 (Supplement 1): 8418–8419.

https://doi.org/10.1182/blood-2022-163458

Published: 2022

Journal Articles

Comparable Outcomes Following Non-First-Degree and First-Degree Related Donor Haploidentical Hematopoietic Cell Transplantation for Acute Leukemia Patients in Complete Remission: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Yishan Ye, Myriam Labopin, Jia Chen, Zafer Gulbas, Xi Zhang, Yener Koc, Didier Blaise, Fabio Ciceri, Emmanuelle Polge, Houhou Mohamad, Lin Li, Yi Luo, Depei Wu, He Huang, Mohamad Mohty, Norbert Claude Gorin, Sr.

Blood (2022) 140 (Supplement 1): 10603–10605.

https://doi.org/10.1182/blood-2022-158482

Published: 2022

Journal Articles

Inhibition of LDHA to induce eEF2 release enhances thrombocytopoiesis

Qidi Chen, Min Xin, Lingjun Wang, Lin Li, Yingzhi Shen, Yan Geng, Haojie Jiang, Yang Wang, Lin Zhang, Yanyan Xu, Yu Hou, Junling Liu, Xuemei Fan

Blood (2022) 139 (19): 2958–2971.

https://doi.org/10.1182/blood.2022015620

Published: 2022

Includes: Supplemental data

Journal Articles

MRI-Derived Radiomics of Hemophilic Arthropathy Is Associated with Severity of Joint Disease

Bolin Song, Vidya Sankar Sankar Viswanathan, Jonathan Nutt, Lin Li, Navid Faraji, Christos Kosmas, Anant Madabhushi, Sanjay Ahuja

Blood (2021) 138 (Supplement 1): 2958.

https://doi.org/10.1182/blood-2021-151003

Published: 2021

Journal Articles

Prognostic Prediction with Static-Dynamic Clinical and Pathological Parameters By Machine Learning Algorithm in Acute Lymphoblastic Leukemia

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, Wen-Chien Chou, MD PhD, Hwei-Fang Tien, MD, PhD, Ting-Yu Chang, M.S., Chi-Chun Lee, PhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-139766

Published: 2020

Journal Articles

Accurate Prediction of Gene Mutations with Flow Cytometry Immune-Phenotyping By Machine Learning Algorithm

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, Wen-Chien Chou, MD PhD, Hwei-Fang Tien, MD, PhD, Ting-Yu Chang, M.S., Chi-Chun Lee, PhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-139623

Published: 2020

Journal Articles

Relapse and Mortality Prediction of Acute Myeloid Leukemia Patients Using Deep Bidirectional Long Short-Term Memory-Deep Neural Network Architecture

Bor-Sheng Ko, MD PhD, Yu-Fen Wang, MS, Chih-Chuan Lu, B.S., Jeng-Lin Li, BS, Chi-Chun Lee, PhD, Jih-Luh Tang, MD, Hwei-Fang Tien, MD, PhD

Blood (2018) 132 (Supplement 1): 2811.

https://doi.org/10.1182/blood-2018-99-115778

Published: 2018

Journal Articles

An Artificial Intelligence Approach for B Lymphoblastic Leukemia Minimal Residual Disease Detection and Clinical Prognosis Prediction Using Flow Cytometry Data

Yu-Fen Wang, MS, Bor-Sheng Ko, MD, PhD, Chi-Cheng Li, MD, Jeng-Lin Li, BS, Pei-Fang Weng, BS, Huai-Hsuan Huang, MD, Hsin-An Hou, MD, PhD, Hwei-Fang Tien, MD, PhD, Chi-Chun Lee, PhD, Jih-Luh Tang, MD,PhD

Blood (2017) 130 (Supplement 1): 3980.

https://doi.org/10.1182/blood.V130.Suppl_1.3980.3980

Published: 2017

Journal Articles

An Artificial Intelligence Approach for Predicting Allogeneic Hematopoietic Stem Cell Transplantation Outcome By Detecting Pre-Transplant Minimal Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry Data

Chi-Cheng Li, MD, Bor-Sheng Ko, MD, PhD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Pei-Fang Weng, BS, Hsin-An Hou, MD, PhD, Xiu-Wen Liao, MS, Chien-Ting Lin, MD, Jia-Hou Liu, MD, Hsun-I Sun, Hwei-Fang Tien, MD, PhD, Chi-Chun Lee, PhD, Jih-Luh Tang, MD,PhD

Blood (2017) 130 (Supplement 1): 2042.

https://doi.org/10.1182/blood.V130.Suppl_1.2042.2042

Published: 2017

Journal Articles

An Artificial Intelligence Approach in Classifying Acute Myeloid Leukemia and Myelodysplastic Syndrome for Minimal Residual Disease Detection with Post Induction Prognosis Analysis Using Flow Cytometry

Bor-Sheng Ko, MD, PhD, Chi-Cheng Li, MD, Yu-Fen Wang, MS, Jeng-Lin Li, BS, Hsin-An Hou, MD, PhD, Pei-Fang Weng, BS, Hwei-Fang Tien, MD, PhD, Chi-Chun Lee, PhD, Jih-Luh Tang, MD,PhD

Blood (2017) 130 (Supplement 1): 1403.

https://doi.org/10.1182/blood.V130.Suppl_1.1403.1403

Published: 2017

Journal Articles

Therapeutic Immune Monitoring of Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors: Focus on CD4 + CD25 + t Cells

Ziyuan Lu, Na Xu, MD, Xuan Zhou, MD, Guanlun Gao, Lin Li, Jixian Huang, Yuling Li, Qisi Lu, Bolin He, Chengyun Pan, Liu Xiaoli, MD

Blood (2015) 126 (23): 4036.

https://doi.org/10.1182/blood.V126.23.4036.4036

Published: 2015

Journal Articles

LOXL2 Highly-Expressed Induce the Transition of Stromal Cells into Cancer-Associated Fibroblasts Which Maybe Involve in Myeloproliferative Neoplasms Progession

Na Xu, MD, Yuling Li, Xuan Zhou, MD, Lin Li, Qisi Lu, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2015) 126 (23): 5207.

https://doi.org/10.1182/blood.V126.23.5207.5207

Published: 2015

Journal Articles

EphB4/EphrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins

Lin Li, Na Xu, MD, Xuan Zhou, MD, Yuling Li, Qisi Lu, Ziyuan Lu, Jixian Huang, Bolin He, Chengyun Pan, Qifa Liu, MD, Liu Xiaoli, MD

Blood (2015) 126 (23): 5135.

https://doi.org/10.1182/blood.V126.23.5135.5135

Published: 2015

NARROW

Sonrotoclax overcomes BCL2 G101V mutation–induced venetoclax resistance in preclinical models of hematologic malignancy

Monitoring the Sign & Symptoms of Variant Creutzfeldt-Jakob Disease Among Patients with Multiple Myeloma Treated with Ixazomib Capsules in China: A Real-World Pharmacovigilance Survey

A Multi-Center Retrospective Analysis of Outcomes Post Allogeneic Stem Cell Transplantation in AML Patients with TET2 Mutations: A Study on Behalf of the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Comparative Study for Haplo, MSD and MUD Allo-Hcts for AML Patients with KMT2A Rearrangement: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Comparative Study for Haplo, MSD and MUD Allo-Hcts for Core-Binding Factor AML Patients in CR2: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Treatment Patterns and Outcomes in Patients with Multiple Myeloma Who Received Ixazomib and in Patients with Triple-Class Refractory Multiple Myeloma: A Retrospective, Observational, Real-World Historical Database Analysis Study from China

Characteristics and Safety Profile in Patient Received Ixazomib in China: Interim Analysis of a National, Prospective, Non-Interventional Study of Using Ixazomib in Real-World Clinical Practice (INFINITE Study)

Gut-Bile Acid-Immune Axis Regulates T Cell Homeostasis in the Pathogenesis of Immune Thrombocytopenia

Inhibition of LDHA to induce eEF2 release enhances thrombocytopoiesis

MRI-Derived Radiomics of Hemophilic Arthropathy Is Associated with Severity of Joint Disease

Prognostic Prediction with Static-Dynamic Clinical and Pathological Parameters By Machine Learning Algorithm in Acute Lymphoblastic Leukemia

Accurate Prediction of Gene Mutations with Flow Cytometry Immune-Phenotyping By Machine Learning Algorithm

Relapse and Mortality Prediction of Acute Myeloid Leukemia Patients Using Deep Bidirectional Long Short-Term Memory-Deep Neural Network Architecture

An Artificial Intelligence Approach for B Lymphoblastic Leukemia Minimal Residual Disease Detection and Clinical Prognosis Prediction Using Flow Cytometry Data

An Artificial Intelligence Approach for Predicting Allogeneic Hematopoietic Stem Cell Transplantation Outcome By Detecting Pre-Transplant Minimal Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry Data

An Artificial Intelligence Approach in Classifying Acute Myeloid Leukemia and Myelodysplastic Syndrome for Minimal Residual Disease Detection with Post Induction Prognosis Analysis Using Flow Cytometry

Therapeutic Immune Monitoring of Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors: Focus on CD4 + CD25 + t Cells

LOXL2 Highly-Expressed Induce the Transition of Stromal Cells into Cancer-Associated Fibroblasts Which Maybe Involve in Myeloproliferative Neoplasms Progession

EphB4/EphrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only